(WASHINGTON, DC) Clinical research innovators came together from across the country at the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials. We joined attendees from across the industry to celebrate last year’s achievements, discuss industry missteps, and investigate the future of clinical trials.
(WASHINGTON, DC) At mProve Health, Quality and Information Security are paramount to the way we do business. However, we don’t get to talk about it much: it has always seemed to us that operating a robust Quality/Information Security program should be a given, not something to grandstand about.
BYOD supporters are in luck: If you want to see the bring-your-own-device movement get better, there is new data showing that industry leaders aren’t as opposed to BYOD as you may think. Applied Clinical Trials recently published a study that surveyed lead eCOA providers (and those related) on their opinions. mProve Founder and CEO Jeff Lee coauthored the article with Bill Byrom of ICON and other thought leaders within ICON and Medidata.
Washington, D.C. (September 5, 2014) – mProve Health, a leader in providing mobile technology services to the life sciences sector, announces the addition of T. Hephner to its team. Hephner has joined mProve as Vice President of Business Development.
Mr. Hephner brings over 15 years of business development, sales and marketing experience to mProve Health. A co-founder of Praxis, a leading patient recruitment provider, and a seasoned veteran of the clinical research world, Mr. Hephner will bring these experiences to one of the fastest growing companies in the life sciences arena.
Mr. Hephner is joining the team during a period of major expansion by mProve. Since its founding in 2010, mProve has steadily grown into a leadership position in the mHealth field, with a focus on the use of mobile devices to create clinical study efficiencies in the areas of patient recruitment, retention and in the collection of patient-reported outcomes. With revolutionary products and applications that allow for usage of participants’ own mobile devices, mProve has emerged as an industry leader in patient engagement products via mobile platform and is leading the way in next generation clinical trials.
As of Monday, 17-March 2014, Omniscience Mobile is announcing its new name, mProve Health. Find out more about our us by visiting our new site, and let us know what you think by getting in touch. We look forward to hearing from you and continuing to provide the same high-quality services to our clients as we have since 2010.